2022
Exports
$11.8BWorld Rnk 7 / 208
Flag Rnk 5 / 1217
2022
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.38Rnk 75 / 1025
2022
Imports
$12.1BWorld Rnk 8 / 225
Flag Rnk 6 / 1215
2022
ECONOMIC COMPLEXITY of Italy
1.29Rnk 17 / 133

About

Exports In 2022, Italy exported $11.8B in Vaccines, blood, antisera, toxins and cultures, making it the 7th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 5th most exported product in Italy. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Italy are: United States ($2.66B), Netherlands ($2.62B), Belgium ($1.4B), Germany ($1.11B), and Poland ($616M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Italy between 2021 and 2022 were United States ($755M), Netherlands ($522M), and Poland ($235M).

Imports In 2022, Italy imported $12.1B in Vaccines, blood, antisera, toxins and cultures, becoming the 8th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most imported product in Italy. Italy imports Vaccines, blood, antisera, toxins and cultures primarily from: N/A.

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Italy between 2021 and 2022 were South Korea ($240M), Belgium ($204M), and Germany ($157M).

Latest Trends

August 2024

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (August 2023 - August 2024)€411M(44.9%)
IMPORT GROWTH (August 2023 - August 2024)€202M(27.4%)
MAIN DESTINATION (August 2024)United States€529M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Italy. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$11.8B
IMPORTS (2022)$12.1B
NET TRADE (2022)-$341M

In 2022, Italy exported $11.8B in Vaccines, blood, antisera, toxins and cultures. The main destinations of Italy exports on Vaccines, blood, antisera, toxins and cultures were United States ($2.66B), Netherlands ($2.62B), Belgium ($1.4B), Germany ($1.11B), and Poland ($616M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Italy WERE (2021 - 2022):
United States$755M (39.7%)
Netherlands$522M (24.9%)
Poland$235M (61.6%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Italy WERE (2021 - 2022):
Germany-$298M (-21.2%)
Sweden-$76.3M (-67.9%)
Russia-$40M (-63.7%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Italy's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2022, Italy's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALUnited States+ $498M
TOP IMPORT POTENTIALSwitzerland+ $597M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is United States. With an export gap of $498M.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is Switzerland with an import gap of $597M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with